+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Market by Product Type, Therapeutic Area, Technology, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Biologics Market by Product Type, Therapeutic Area, Technology, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Biologics Market by Product Type, Therapeutic Area, Technology, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082738
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologics market is entering a pivotal phase, marked by advances in research, regulatory evolution, and supply chain recalibration. Senior executives seeking to unlock new growth avenues, streamline operations, and anticipate competitive shifts will find actionable intelligence in this comprehensive industry review.

Market Snapshot: Biologics Market Overview

The biologics market is set for robust expansion, having grown from USD 430.59 billion in 2024 to USD 459.45 billion in 2025. Forecasts indicate continued momentum, with the sector projected to achieve a CAGR of 6.45% and reach USD 626.76 billion by 2030. This upward trend is driven by the convergence of maturing recombinant technologies, expanded cell and gene therapies, and a dynamic regulatory environment. Providers and investors must adapt rapidly as biologics take center stage in modern therapeutics.

Scope & Segmentation of the Biologics Market

This report meticulously categorizes the biologics market by product type, therapeutic application, enabling technology, administration route, end-use, and distribution model, covering a broad geographic scope. Each segmentation is analyzed to provide strategic clarity for diverse stakeholder priorities.

  • Product Types: Blood factor products; cell therapies (including CAR-T, hematopoietic, and mesenchymal stem cell therapies); gene therapies (adeno-associated virus, lentiviral vector); monoclonal antibodies (chimeric, human, humanized, murine); recombinant proteins (enzymes, growth factors, hormones); vaccines (inactivated, live attenuated, recombinant).
  • Therapeutic Areas: Autoimmune diseases; cardiovascular diseases; infectious diseases; metabolic and neurological disorders; oncology (with subcategories for hematological malignancies and solid tumors such as breast, colorectal, lung, and prostate cancer).
  • Technology Platforms: Cell culture; gene editing (CRISPR, TALENs, zinc finger nucleases); hybridoma; recombinant DNA methodologies.
  • Route of Administration: Intramuscular; intravenous; subcutaneous.
  • End Users: Clinics; home healthcare settings; hospitals; research institutes.
  • Distribution Channels: Distribution partners; hospital and retail pharmacies; online channels.
  • Regions Covered: Americas (including the United States, Canada, Brazil, and more); Europe, Middle East & Africa (with focus countries such as the UK, Germany, France, and others); Asia-Pacific (including China, India, Japan, Australia, and others).
  • Company Coverage: Analysis of key players such as Roche Holding AG, AbbVie Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Merck & Co., Sanofi S.A., Amgen Inc., Bristol-Myers Squibb, and Gilead Sciences.

Key Takeaways for Senior Decision-Makers

  • Collaboration in research accelerates innovation, with academic and industry partnerships yielding new cell and gene therapy modalities.
  • Digitalization—through AI and advanced analytics—enables data-driven process optimization, helping biomanufacturers achieve consistency and reduce time-to-market.
  • Shifting reimbursement frameworks require evidence of tangible patient outcomes, prompting developers to align product value with payer and provider expectations.
  • Regional variance drives tailored market strategies, with the Americas leveraging R&D intensity, EMEA emphasizing value-based access, and Asia-Pacific exhibiting rapid adoption through harmonized regulation and trial recruitment.
  • Strategic alliances, vertical integration, and investment in novel platforms are essential to navigate complex regulatory, pricing, and supply chain landscapes.
  • Advances in technology platforms, especially gene editing, are reshaping both development timelines and therapeutic targeting, opening new specialization opportunities within biologics.

Tariff Impact on the Biologics Market

Recent changes to US tariff schedules have reshaped global biologics trade. Elevated duties on imported raw materials and equipment compel manufacturers to adjust procurement strategies and consider nearshoring. Contract development and manufacturing organizations are increasingly turning to strategic partnerships to manage cost volatility and ensure supply continuity. Geographic diversification of production emerges as a tactical response, allowing firms to maintain competitive market access despite evolving trade constraints.

Methodology & Data Sources

This assessment draws on a rigorous combination of secondary research and qualitative primary interviews with industry experts, clinical leaders, supply chain specialists, and payers. Triangulation ensured quantitative reliability. The research utilized peer-reviewed journals, regulatory filings, corporate disclosures, and localized market intelligence to underpin findings from multiple vantage points.

Why This Report Matters

  • Supports executive-level strategy formulation by offering granular analysis and actionable insights across biologics sub-segments, technologies, and regions.
  • Informs risk mitigation strategies for supply chain, reimbursement, and regulatory shifts by analyzing structural, policy, and geographic drivers.
  • Empowers informed investment decisions and accelerates strategic planning for innovation, partnership selection, and go-to-market activities within the evolving biologics market landscape.

Conclusion

The biologics sector is evolving with scientific innovation, regulatory adaptation, and emerging commercialization challenges. Organizations prepared with data-driven strategies and diversified alliances will be positioned to drive sustained growth and capitalize on new opportunities in this dynamic market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics Market, by Product Type
8.1. Introduction
8.2. Blood Factor Products
8.3. Cell Therapies
8.3.1. CAR-T Therapies
8.3.2. Hematopoietic Stem Cell Therapy
8.3.3. Mesenchymal Stem Cell Therapy
8.4. Gene Therapies
8.4.1. Adeno Associated Virus
8.4.2. Lentiviral Vector
8.5. Monoclonal Antibodies
8.5.1. Chimeric
8.5.2. Human
8.5.3. Humanized
8.5.4. Murine
8.6. Recombinant Proteins
8.6.1. Enzymes
8.6.2. Growth Factors
8.6.3. Hormones
8.7. Vaccines
8.7.1. Inactivated
8.7.2. Live Attenuated
8.7.3. Recombinant
9. Biologics Market, by Therapeutic Area
9.1. Introduction
9.2. Autoimmune
9.3. Cardiovascular Diseases
9.4. Infectious Diseases
9.5. Metabolic Disorders
9.6. Neurological Disorders
9.7. Oncology
9.7.1. Hematological Malignancies
9.7.1.1. Leukemia
9.7.1.2. Lymphoma
9.7.1.3. Myeloma
9.7.2. Solid Tumors
9.7.2.1. Breast Cancer
9.7.2.2. Colorectal Cancer
9.7.2.3. Lung Cancer
9.7.2.4. Prostate Cancer
10. Biologics Market, by Technology
10.1. Introduction
10.2. Cell Culture Technology
10.3. Gene Editing Technology
10.3.1. CRISPR
10.3.2. TALENs
10.3.3. Zinc Finger Nucleases
10.4. Hybridoma Technology
10.5. Recombinant DNA Technology
11. Biologics Market, by Route Of Administration
11.1. Introduction
11.2. Intramuscular
11.3. Intravenous
11.4. Subcutaneous
12. Biologics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
12.5. Research Institutes
13. Biologics Market, by Distribution Channel
13.1. Introduction
13.2. Distribution Partners
13.3. Hospital Pharmacy
13.4. Online Channel
13.5. Retail Pharmacy
14. Americas Biologics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biologics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biologics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Roche Holding AG
17.3.2. AbbVie Inc.
17.3.3. Pfizer Inc.
17.3.4. Johnson & Johnson
17.3.5. Novartis AG
17.3.6. Merck & Co., Inc.
17.3.7. Sanofi S.A.
17.3.8. Amgen Inc.
17.3.9. Bristol-Myers Squibb Company
17.3.10. Gilead Sciences, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICS MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICS MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY BLOOD FACTOR PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY LENTIVIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS MARKET SIZE, BY MURINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS MARKET SIZE, BY HYBRIDOMA TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 109. CANADA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 110. CANADA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 111. CANADA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 112. CANADA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 113. CANADA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. CANADA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 116. CANADA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 117. CANADA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. CANADA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. CANADA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CANADA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. GERMANY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 200. GERMANY BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 201. GERMANY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 202. GERMANY BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 203. GERMANY BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 205. GERMANY BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 207. GERMANY BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 208. GERMANY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. GERMANY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. GERMANY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. FRANCE BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 216. FRANCE BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 217. FRANCE BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 218. FRANCE BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 219. FRANCE BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 220. FRANCE BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 221. FRANCE BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 222. FRANCE BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 223. FRANCE BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. FRANCE BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. FRANCE BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. FRANCE BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. FRANCE BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. ITALY BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 245. ITALY BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 246. ITALY BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 247. ITALY BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 248. ITALY BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 249. ITALY BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 250. ITALY BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 251. ITALY BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 252. ITALY BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 253. ITALY BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. ITALY BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. ITALY BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. ITALY BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ITALY BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SPAIN BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 260. SPAIN BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 261. SPAIN BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 263. SPAIN BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 264. SPAIN BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 265. SPAIN BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SPAIN BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 267. SPAIN BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 268. SPAIN BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. SPAIN BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. SPAIN BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. SPAIN BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. SPAIN BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. DENMARK BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. DENMARK BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 320. DENMARK BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 321. DENMARK BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 322. DENMARK BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 323. DENMARK BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 324. DENMARK BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 325. DENMARK BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 326. DENMARK BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 327. DENMARK BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 328. DENMARK BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 329. DENMARK BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. DENMARK BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 331. DENMARK BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. DENMARK BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. QATAR BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 349. QATAR BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 350. QATAR BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 351. QATAR BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 352. QATAR BIOLOGICS MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 353. QATAR BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 354. QATAR BIOLOGICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 355. QATAR BIOLOGICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 356. QATAR BIOLOGICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2030 (USD MILLION)
TABLE 357. QATAR BIOLOGICS MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 358. QATAR BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 359. QATAR BIOLOGICS MARKET SIZE, BY GENE EDITING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 360. QATAR BIOLOGICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 361. QATAR BIOLOGICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 362. QATAR BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 363. FINLAND BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 364. FINLAND BIOLOGICS MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 365. FINLAND BIOLOGICS MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 366. FINLAND BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biologics market report include:
  • Roche Holding AG
  • AbbVie Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 459.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 626.76 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cancer Biologics Market by Product Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Cancer Biologics Market by Product Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Biologics Contract Development Market by Service Type, Molecule Type, Therapeutic Area, Host System, End User, Technology - Global Forecast to 2030 - Product Image

Biologics Contract Development Market by Service Type, Molecule Type, Therapeutic Area, Host System, End User, Technology - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Biologics - Global Strategic Business Report - Product Image

Biologics - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.